Clinical Trials Browser

Phase 1/2 × Completed × olaratumab × Clear all

NCT03086369 2022-06-28

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Phase 1/2 Completed

184 enrolled 22 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02659020 2022-05-09

ANNOUNCE 2

Phase 1/2 Completed

310 enrolled 33 charts

Sarcoma

NCT01185964 2017-04-14

A Study of Olaratumab in Soft Tissue Sarcoma

Phase 1/2 Completed

148 enrolled 21 charts

Sarcoma